Multiplication on, multiplication off: Targeting an enzymatic switch to develop oncology drugs

Interdisciplinary research highlighted lipid-protein interaction as a new avenue for oncology drug development, demonstrating its functionality by designing small molecule-based inhibitors to target acute myeloid leukemia.